Table 2.
Comorbidities
| Tiopronin n (%) | Non-tiopronin n (%) | Total n (%) | p value | |
|---|---|---|---|---|
| Chronic anemia | 19 (7.3) | 7 (15.6) | 26 (8.5) | 0.067 |
| Malignancy | 26 (10.0) | 7 (15.6) | 33 (10.8) | 0.264 |
| Coronary artery or cardiovascular disease | 71 (26.9) | 11 (24.4) | 82 (26.5) | 0.861 |
| Pulmonary (respiratory) disease | 27 (10.3) | 4 (8.9) | 31 (10.1) | 0.777 |
| Musculoskeletal diseasea | 51 (19.4) | 16 (35.6) | 67 (21.8) | 0.049 |
| Diabetes | 28 (10.6) | 7 (15.9) | 35 (11.4) | 0.309 |
| Gastrointestinal tract disease | 27 (10.3) | 8 (18.2) | 35 (11.4) | 0.126 |
| Endocrine (e.g., thyroid) disordera | 14 (5.3) | 9 (20.5) | 23 (7.5) | < 0.001 |
| Neurologic disordera | 16 (6.1) | 11 (25.0) | 27 (8.8) | < 0.001 |
| Anxiety | 83 (31.4) | 17 (38.6) | 100 (32.1) | 0.345 |
| Depression | 80 (30.4) | 16 (35.6) | 96 (31.2) | 0.492 |
| Psychiatric disorder (other than anxiety or depression) | 14 (5.3) | 2 (4.5) | 16 (5.2) | 0.834 |
| Skin disordera | 27 (10.2) | 11 (24.4) | 38 (12.3) | 0.007 |
aPearson Chi-squared test p < 0.05